AcelRx Pharmaceuticals Inc (ACRX.O)

ACRX.O on Consolidated Issue listed on NASDAQ Global Market

9.97USD
22 Jul 2014
Price Change (% chg)

$-0.11 (-1.09%)
Prev Close
$10.08
Open
$10.18
Day's High
$10.28
Day's Low
$9.92
Volume
479,555
Avg. Vol
646,245
52-wk High
$13.64
52-wk Low
$6.04

ACRX.O

Chart for ACRX.O

About

AcelRx Pharmaceuticals, Inc. is a United States-based Pharmaceutical Company, which develops and commercializes therapies for the treatment of pain. The Company's products include ARX-01 Sufentanil NanoTab PCA System, to solve the problems associated with post-operative intravenous patient-controlled analgesia (IV PCA); ARX-02... (more)

Overall

Beta: 1.65
Market Cap (Mil.): $437.16
Shares Outstanding (Mil.): 43.37
Dividend: --
Yield (%): --

Financials

  ACRX.O Industry Sector
P/E (TTM): -- 99.85 35.92
EPS (TTM): -0.54 -- --
ROI: -30.33 -0.25 18.26
ROE: -46.66 -1.05 19.14
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Pechala's Reports
$25.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks